Efficacy and Safety of TenoMiR in Lateral Epicondylitis
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study is testing a drug called TenoMiR that is being developed for the treatment of
tennis elbow (lateral epicondylitis). The study drug is a new compound that works by
improving the quality of the collagen which helps repair damage to the elbow. The study drug
is being developed in the hope of providing a more reliable treatment than those currently
available and can be given at the time of first diagnosis, so that recovery can begin as soon
as possible. The study drug has been tested in humans in an earlier study, and appeared to be
safe and well-tolerated. This study aims to test the study drug in a larger number of
participants.